BCRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $475,886.96

Insider Selling (Last 12 Months): $82,486.00

BioCryst Pharmaceuticals Insider Trading History Chart

BioCryst Pharmaceuticals Share Price & Price History

^$9.85

▼ -0.21 (-2.09%)

As of 05/14/2025 05:00 PM ET

Days: 30 | 90 | 365

BioCryst Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/24/2024	Amy E. McKee	Director	Sell	8,600	$6.32	$54,352.00	27,831
6/17/2024	Machelle Sanders	Director	Sell	4,689	$6.00	$28,134.00	27,742
5/30/2024	Alan G Levin	Director	Buy	7,861	$6.36	$49,995.96	44,951
5/24/2024	Steve Aselage	Director	Buy	2,500	$6.40	$16,000.00	2,500
5/20/2024	Nancy J. Hutson	Director	Buy	5,000	$6.38	$31,900.00	86,818
5/14/2024	Anthony Doyle	CFO	Buy	36,300	$5.57	$202,191.00	266,744
5/14/2024	Helen M. Thackray	Insider	Buy	30,000	$5.86	$175,800.00	272,139
5/13/2024	Steven K. Galson	Director	Buy	21,940	$5.49	$120,450.60	51,551
6/15/2023	Machelle Sanders	Director	Sell	4,000	$7.98	$31,920.00	25,611
2/1/2023	Jon P. Stonehouse	CEO	Sell	100,000	$10.38	$1,038,000.00	1,008,739
12/15/2022	Anthony Doyle	CFO	Sell	5,700	$10.90	$62,130.00	163,966
12/15/2022	Helen M. Thackray	Insider	Sell	3,125	$10.89	$34,031.25	133,275
12/15/2022	Jon P. Stonehouse	CEO	Sell	14,100	$10.90	$153,690.00	887,730
12/15/2022	Michael L Jones	Director	Sell	445	$10.90	$4,850.50	10,753
12/2/2022	Jon P. Stonehouse	CEO	Sell	82,656	$12.80	$1,057,996.80	901,830
12/1/2022	Michael L Jones	Director	Sell	8,600	$13.01	$111,886.00	11,198
11/14/2022	Yarlagadda S. Babu	Insider	Sell	31,515	$13.88	$437,428.20	298,541

See Full Table

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

85.88% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/14/2025	MetLife Investment Management LLC	121,918	$0.91M	0.0%	-4.0%	0.058%
5/14/2025	Walleye Capital LLC	154,692	$1.16M	0.0%	-56.6%	0.074%
5/14/2025	Jump Financial LLC	148,849	$1.12M	0.0%	-43.5%	0.071%
5/14/2025	Northwestern Mutual Wealth Management Co.	6,127	$46K	0.0%	-30.9%	0.003%
5/14/2025	AlphaQuest LLC	62,646	$0.47M	0.1%	+120.3%	0.030%
5/14/2025	EntryPoint Capital LLC	40,528	$0.30M	0.1%	N/A	0.019%
5/14/2025	Wellington Management Group LLP	91,348	$0.69M	0.0%	+2.6%	0.044%
5/13/2025	Northern Trust Corp	1,955,258	$14.66M	0.0%	-2.5%	0.934%
5/13/2025	Algert Global LLC	960,057	$7.20M	0.2%	+32.4%	0.459%
5/13/2025	American Century Companies Inc.	137,713	$1.03M	0.0%	-11.2%	0.066%
5/13/2025	Fox Run Management L.L.C.	29,425	$0.22M	0.0%	-56.8%	0.014%
5/13/2025	Sei Investments Co.	44,419	$0.33M	0.0%	-22.3%	0.021%
5/13/2025	E Fund Management Co. Ltd.	23,674	$0.18M	0.0%	+42.5%	0.011%
5/13/2025	Russell Investments Group Ltd.	103,329	$0.78M	0.0%	+269.5%	0.049%
5/12/2025	Knott David M Jr	460,000	$3.45M	1.6%	+4.5%	0.220%
5/12/2025	Nuveen LLC	1,423,646	$10.68M	0.0%	N/A	0.680%
5/12/2025	Invesco Ltd.	968,155	$7.26M	0.0%	-9.7%	0.463%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	1,042,424	$7.82M	0.0%	+64.5%	0.498%
5/12/2025	Swiss National Bank	381,268	$2.86M	0.0%	-1.4%	0.182%
5/9/2025	Headlands Technologies LLC	4,219	$32K	0.0%	N/A	0.002%
5/9/2025	Deutsche Bank AG	496,042	$3.72M	0.0%	-4.5%	0.237%
5/9/2025	Charles Schwab Investment Management Inc.	1,922,038	$14.42M	0.0%	-2.9%	0.919%
5/9/2025	Vanguard Group Inc.	21,659,765	$162.45M	0.0%	-1.1%	10.353%
5/9/2025	New Age Alpha Advisors LLC	8,235	$62K	0.0%	N/A	0.004%
5/9/2025	R Squared Ltd	11,670	$88K	0.1%	+84.2%	0.006%
5/9/2025	PNC Financial Services Group Inc.	15,899	$0.12M	0.0%	-7.8%	0.008%
5/9/2025	Jupiter Asset Management Ltd.	2,148,969	$16.12M	0.2%	+82.4%	1.027%
5/8/2025	XTX Topco Ltd	87,389	$0.66M	0.0%	+314.8%	0.042%
5/8/2025	GSA Capital Partners LLP	278,552	$2.09M	0.2%	+69.3%	0.133%
5/8/2025	Federated Hermes Inc.	184,904	$1.39M	0.0%	+10.1%	0.088%
5/7/2025	Mackenzie Financial Corp	116,258	$0.87M	0.0%	+37.3%	0.056%
5/7/2025	Corton Capital Inc.	16,269	$0.12M	0.4%	-49.7%	0.008%
5/6/2025	Legato Capital Management LLC	22,122	$0.17M	0.0%	-6.2%	0.011%
5/6/2025	Universal Beteiligungs und Servicegesellschaft mbH	16,704	$0.13M	0.0%	N/A	0.008%
5/6/2025	Y Intercept Hong Kong Ltd	141,865	$1.06M	0.1%	+106.7%	0.068%
5/5/2025	GW&K Investment Management LLC	2,884,680	$21.64M	0.2%	-1.9%	1.379%
5/5/2025	Allianz Asset Management GmbH	13,700	$0.10M	0.0%	+9.6%	0.007%
5/5/2025	Hussman Strategic Advisors Inc.	315,000	$2.36M	0.6%	N/A	0.151%
5/2/2025	Segall Bryant & Hamill LLC	1,330,314	$9.98M	0.2%	-6.5%	0.636%
5/1/2025	Rice Hall James & Associates LLC	2,027,568	$15.21M	0.9%	-2.6%	0.970%
5/1/2025	CWM LLC	53,750	$0.40M	0.0%	+167.5%	0.026%
4/30/2025	Cerity Partners LLC	36,410	$0.27M	0.0%	+203.6%	0.017%
4/30/2025	Alps Advisors Inc.	152,985	$1.15M	0.0%	-8.7%	0.073%
4/30/2025	China Universal Asset Management Co. Ltd.	41,914	$0.31M	0.0%	-4.6%	0.020%
4/29/2025	Bank of New York Mellon Corp	589,877	$4.42M	0.0%	-1.2%	0.282%
4/28/2025	Principal Financial Group Inc.	16,495	$0.12M	0.0%	-7.4%	0.008%
4/28/2025	Teacher Retirement System of Texas	52,961	$0.40M	0.0%	-9.1%	0.025%
4/24/2025	Allspring Global Investments Holdings LLC	10,574	$79K	0.0%	N/A	0.005%
4/17/2025	Grimes & Company Inc.	72,707	$0.55M	0.0%	-3.4%	0.035%
4/17/2025	Janney Montgomery Scott LLC	50,661	$0.38M	0.0%	-8.1%	0.024%
4/16/2025	Wealth Enhancement Advisory Services LLC	37,671	$0.28M	0.0%	+113.7%	0.018%
4/15/2025	SG Americas Securities LLC	43,496	$0.33M	0.0%	+5.2%	0.021%
4/14/2025	Pallas Capital Advisors LLC	19,797	$0.15M	0.0%	N/A	0.009%
4/9/2025	Merit Financial Group LLC	13,360	$100K	0.0%	N/A	0.006%
4/8/2025	Rhumbline Advisers	321,154	$2.41M	0.0%	+3.9%	0.154%
4/7/2025	GAMMA Investing LLC	5,918	$44K	0.0%	+1,161.8%	0.003%
4/4/2025	Moody National Bank Trust Division	58,152	$0.44M	0.0%	-3.7%	0.028%
3/24/2025	Wellington Management Group LLP	89,057	$0.67M	0.0%	-17.4%	0.043%
3/18/2025	California State Teachers Retirement System	184,485	$1.39M	0.0%	+4.1%	0.088%
2/27/2025	Pinnacle Wealth Planning Services Inc.	12,710	$96K	0.0%	-48.6%	0.006%
2/20/2025	Mackenzie Financial Corp	84,662	$0.64M	0.0%	+190.7%	0.041%
2/19/2025	GF Fund Management CO. LTD.	4,349	$33K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	401,111	$3.02M	0.0%	+3.0%	0.194%
2/17/2025	Voloridge Investment Management LLC	1,579,960	$11.88M	0.0%	-11.9%	0.763%
2/17/2025	Woodline Partners LP	450,199	$3.39M	0.0%	N/A	0.217%
2/17/2025	Visionary Wealth Advisors	26,590	$0.20M	0.0%	-4.3%	0.013%
2/17/2025	Two Sigma Advisers LP	2,499,812	$18.80M	0.0%	+14.6%	1.207%
2/17/2025	Two Sigma Investments LP	1,774,214	$13.34M	0.0%	+0.8%	0.857%
2/17/2025	Teza Capital Management LLC	47,874	$0.36M	0.1%	-9.2%	0.023%
2/17/2025	State of Wyoming	42,303	$0.32M	0.0%	-19.4%	0.020%
2/17/2025	Sherbrooke Park Advisers LLC	34,628	$0.26M	0.1%	+25.9%	0.017%
2/17/2025	Rafferty Asset Management LLC	234,836	$1.77M	0.0%	-36.7%	0.113%
2/17/2025	ProShare Advisors LLC	68,004	$0.51M	0.0%	+32.6%	0.033%
2/17/2025	Quantinno Capital Management LP	14,828	$0.11M	0.0%	+38.2%	0.007%
2/17/2025	Parkman Healthcare Partners LLC	216,881	$1.63M	0.2%	-53.3%	0.105%
2/17/2025	Man Group plc	89,954	$0.68M	0.0%	+46.3%	0.043%
2/17/2025	Nuveen Asset Management LLC	3,419,046	$25.71M	0.0%	-29.0%	1.651%
2/17/2025	Millennium Management LLC	790,105	$5.94M	0.0%	-44.5%	0.381%
2/17/2025	Lazard Asset Management LLC	161,516	$1.21M	0.0%	+68.1%	0.078%
2/17/2025	Jacobs Levy Equity Management Inc.	247,795	$1.86M	0.0%	-32.6%	0.120%
2/17/2025	Graham Capital Management L.P.	97,257	$0.73M	0.0%	N/A	0.047%
2/17/2025	D. E. Shaw & Co. Inc.	315,263	$2.37M	0.0%	+37.6%	0.152%
2/17/2025	Deutsche Bank AG	519,217	$3.91M	0.0%	+12.7%	0.251%
2/17/2025	Deerfield Management Company L.P. Series C	8,144,442	$61.25M	1.2%	+0.1%	3.932%
2/17/2025	Corton Capital Inc.	32,337	$0.24M	0.1%	-18.1%	0.016%
2/17/2025	Brevan Howard Capital Management LP	56,644	$0.43M	0.0%	-28.7%	0.027%
2/17/2025	Balyasny Asset Management L.P.	529,653	$3.98M	0.0%	N/A	0.256%
2/17/2025	Bayesian Capital Management LP	25,700	$0.19M	0.0%	N/A	0.012%
2/17/2025	Bank of America Corp DE	899,838	$6.77M	0.0%	-22.5%	0.434%
2/17/2025	BNP Paribas Financial Markets	196,225	$1.48M	0.0%	-60.5%	0.095%
2/17/2025	Ameriprise Financial Inc.	1,720,581	$12.94M	0.0%	-2.9%	0.831%
2/17/2025	Algert Global LLC	725,305	$5.45M	0.1%	+40.5%	0.350%
2/14/2025	Caligan Partners LP	2,995,932	$22.53M	6.0%	+16.0%	1.446%
2/14/2025	Freestone Grove Partners LP	30,313	$0.23M	0.0%	N/A	0.015%
2/14/2025	Schonfeld Strategic Advisors LLC	217,740	$1.64M	0.0%	+27.3%	0.105%
2/14/2025	AQR Capital Management LLC	839,274	$6.31M	0.0%	+6.6%	0.405%
2/14/2025	Northern Trust Corp	2,004,911	$15.08M	0.0%	+7.7%	0.968%
2/14/2025	The Manufacturers Life Insurance Company	103,531	$0.78M	0.0%	-65.4%	0.050%
2/14/2025	Tudor Investment Corp ET AL	99,450	$0.75M	0.0%	N/A	0.048%
2/14/2025	Aquatic Capital Management LLC	55,890	$0.42M	0.0%	-58.9%	0.027%

Data available starting January 2016

See Full Table

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

Today's Range

Now: $9.85

$9.77

$10.22

50 Day Range

MA: $7.96

$6.41

$11.03

52 Week Range

Now: $9.85

$5.35

$11.11

Volume

8,983,531 shs

Average Volume

3,034,710 shs

Market Capitalization

$2.06 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top insider shareholders include:
Helen M Thackray (Insider)
Anthony Doyle (CFO)
Nancy J Hutson (Director)
Steven K Galson (Director)
Alan G Levin (Director)
Amy E Mckee (Director)
Machelle Sanders (Director)
Steve Aselage (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.
Who are the major institutional investors of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top institutional shareholders include:
Vanguard Group Inc. — 10.35%
GW&K Investment Management LLC — 1.38%
Jupiter Asset Management Ltd. — 1.03%
Rice Hall James & Associates LLC — 0.97%
Northern Trust Corp — 0.93%
Charles Schwab Investment Management Inc. — 0.92%
Learn More about top institutional investors of BioCryst Pharmaceuticals stock.
Which major investors are selling BioCryst Pharmaceuticals stock?: During the last quarter, BCRX stock was sold by these institutional investors:
Vanguard Group Inc.
Walleye Capital LLC
Jump Financial LLC
Invesco Ltd.
Segall Bryant & Hamill LLC
Charles Schwab Investment Management Inc.
GW&K Investment Management LLC
Rice Hall James & Associates LLC
Within the previous year, company insiders that have sold BioCryst Pharmaceuticals company stock include:
Helen M Thackray (Insider)
Anthony Doyle (CFO)
Learn More investors selling BioCryst Pharmaceuticals stock.
Which major investors are buying BioCryst Pharmaceuticals stock?: Within the previous quarter, BCRX stock was bought by institutional investors including:
Nuveen LLC
Jupiter Asset Management Ltd.
Connor Clark & Lunn Investment Management Ltd.
Hussman Strategic Advisors Inc.
Algert Global LLC
GSA Capital Partners LLP
Simplex Trading LLC
Russell Investments Group Ltd.
In the previous year, these company insiders have bought BioCryst Pharmaceuticals stock:
Helen M Thackray (Insider)
Anthony Doyle (CFO)
Nancy J Hutson (Director)
Steven K Galson (Director)
Alan G Levin (Director)
Amy E Mckee (Director)
Learn More investors buying BioCryst Pharmaceuticals stock.